M. Davidson

712 total citations
27 papers, 507 citations indexed

About

M. Davidson is a scholar working on Psychiatry and Mental health, Genetics and Clinical Psychology. According to data from OpenAlex, M. Davidson has authored 27 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Psychiatry and Mental health, 4 papers in Genetics and 4 papers in Clinical Psychology. Recurrent topics in M. Davidson's work include Schizophrenia research and treatment (5 papers), Attention Deficit Hyperactivity Disorder (4 papers) and Body Image and Dysmorphia Studies (2 papers). M. Davidson is often cited by papers focused on Schizophrenia research and treatment (5 papers), Attention Deficit Hyperactivity Disorder (4 papers) and Body Image and Dysmorphia Studies (2 papers). M. Davidson collaborates with scholars based in United States, Canada and Switzerland. M. Davidson's co-authors include Peter Powchik, Vahram Haroutunian, Steven M. Gabriel, Keith L. Davis, P.D. Harvey, Dushyant P. Purohit, D. P. Perl, S Mukherjee, Patrick Gagnon‐Sanschagrin and Troy D. Wolter and has published in prestigious journals such as Circulation, Blood and Gastroenterology.

In The Last Decade

M. Davidson

23 papers receiving 477 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Davidson United States 11 182 142 121 75 63 27 507
Josiane Bourque Canada 14 141 0.8× 77 0.5× 43 0.4× 172 2.3× 90 1.4× 29 538
Major R. Bradshaw United States 8 80 0.4× 259 1.8× 150 1.2× 57 0.8× 136 2.2× 10 988
Leticia González-Blanco Spain 14 314 1.7× 78 0.5× 69 0.6× 55 0.7× 183 2.9× 65 659
Alison Merikangas United States 12 138 0.8× 34 0.2× 97 0.8× 119 1.6× 132 2.1× 19 580
Rachel Galioto United States 13 187 1.0× 71 0.5× 35 0.3× 82 1.1× 43 0.7× 38 480
Antonietta Scaffidi Australia 6 113 0.6× 29 0.2× 62 0.5× 67 0.9× 79 1.3× 7 364
Liis Merenäkk Estonia 12 66 0.4× 58 0.4× 46 0.4× 58 0.8× 164 2.6× 15 410
Laura M. Huckins United States 13 61 0.3× 44 0.3× 107 0.9× 69 0.9× 126 2.0× 41 511
Laura Ortega Spain 14 224 1.2× 65 0.5× 63 0.5× 28 0.4× 121 1.9× 29 617
Allan M. Andersen United States 12 52 0.3× 84 0.6× 270 2.2× 27 0.4× 117 1.9× 26 513

Countries citing papers authored by M. Davidson

Since Specialization
Citations

This map shows the geographic impact of M. Davidson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Davidson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Davidson more than expected).

Fields of papers citing papers by M. Davidson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Davidson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Davidson. The network helps show where M. Davidson may publish in the future.

Co-authorship network of co-authors of M. Davidson

This figure shows the co-authorship network connecting the top 25 collaborators of M. Davidson. A scholar is included among the top collaborators of M. Davidson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Davidson. M. Davidson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gagnon‐Sanschagrin, Patrick, M. Davidson, Cynthia Willey, et al.. (2024). The economic impact of suboptimal treatment and treatment switch among patients with Crohn’s disease treated with a first-line biologic – A US retrospective claims database study. Journal of Medical Economics. 27(1). 931–940. 1 indexed citations
2.
Gagnon‐Sanschagrin, Patrick, M. Davidson, Cynthia Willey, et al.. (2023). Su1137 SUBOPTIMAL TREATMENT IN PATIENTS WITH CROHN'S DISEASE USING BIOLOGICS. Gastroenterology. 164(6). S–541. 1 indexed citations
3.
Schein, Jeff, Lenard A. Adler, Ann Childress, et al.. (2022). Economic burden of attention-deficit/hyperactivity disorder among children and adolescents in the United States: a societal perspective. Journal of Medical Economics. 25(1). 193–205. 35 indexed citations
4.
Oladapo, Abiola, et al.. (2022). Avatrombopag Treatment Response in Patients with Immune Thrombocytopenia: A Real-World Evidence Study. Blood. 140(Supplement 1). 10889–10890.
5.
Adler, Lenard A., Ann Childress, Martin Cloutier, et al.. (2021). ED4 Economic Burden of Attention-Deficit/Hyperactivity Disorder (ADHD) Among Children and Adolescents in the United States (US): A Societal Perspective. Value in Health. 24. S6–S7. 3 indexed citations
6.
Gauthier‐Loiselle, Marjolaine, Martin Cloutier, Anish Patel, et al.. (2021). Nusinersen for Spinal Muscular Atrophy in the United States: Findings From a Retrospective Claims Database Analysis. Advances in Therapy. 38(12). 5809–5828. 13 indexed citations
7.
Adler, Lenard A., Ann Childress, Martin Cloutier, et al.. (2021). PMH4 Economic Burden of Attention-Deficit/Hyperactivity Disorder (ADHD) Among Adults in the United States: A Societal Perspective. Value in Health. 24. S128–S128. 1 indexed citations
8.
Schein, Jeff, Lenard A. Adler, Ann Childress, et al.. (2021). Economic burden of attention-deficit/hyperactivity disorder among adults in the United States: a societal perspective. Journal of Managed Care & Specialty Pharmacy. 28(2). 168–179. 24 indexed citations
9.
Shah, Nirmish, Menaka Bhor, Dominick Latrémouille-Viau, et al.. (2020). Vaso-occlusive crises and costs of sickle cell disease in patients with commercial, Medicaid, and Medicare insurance – the perspective of private and public payers. Journal of Medical Economics. 23(11). 1345–1355. 24 indexed citations
10.
Joseph, George J, Dominick Latrémouille-Viau, Patrick Gagnon‐Sanschagrin, et al.. (2019). Vaso-Occlusive Crises and Costs of Sickle Cell Disease from a Commercial Payer's Perspective. Blood. 134(Supplement_1). 3464–3464. 2 indexed citations
11.
Davidson, M., et al.. (2014). S.02.04 Employment status in patients with schizophrenia and bipolar disorders. European Neuropsychopharmacology. 24. S112–S112.
12.
13.
Caspi, Asaf, et al.. (2003). Increased risk for schizophrenia in siblings of patients with schizotypal personality disorder. Schizophrenia Research. 60(1). 36–36. 1 indexed citations
14.
Hays, J. Taylor, Ivana T. Croghan, Darrell R. Schroeder, et al.. (1999). Over-the-counter nicotine patch therapy for smoking cessation: results from randomized, double-blind, placebo-controlled, and open label trials.. American Journal of Public Health. 89(11). 1701–1707. 85 indexed citations
15.
Davidson, M. & Martin Brecher. (1999). LONG-TERM EFFICACY, SAFETY, AND TOLERABILITY OF RISPERIDONE IN ELDERLY PSYCHOTIC PATIENTS. American Journal of Geriatric Psychiatry. 7. 41–42. 3 indexed citations
16.
Powchik, Peter, M. Davidson, Vahram Haroutunian, et al.. (1998). Postmortem Studies in Schizophrenia. Schizophrenia Bulletin. 24(3). 325–341. 150 indexed citations
17.
Davidson, M.. (1998). Efficacy and Safety of an Over-the-counter Transdermal Nicotine Patch as an Aid for Smoking Cessation. Archives of Family Medicine. 7(6). 569–574. 47 indexed citations
18.
Frecska, Ede, Miklos Losonczy, R.S.E. Keefe, et al.. (1994). Age dependent change of ventricular measures in schizophrenia: Cross-sectional analysis. Biological Psychiatry. 35(9). 704–705. 4 indexed citations
19.
Silverman, J. M., R C Mohs, M. Davidson, et al.. (1987). Familial schizophrenia and treatment response. American Journal of Psychiatry. 144(10). 1271–1276. 24 indexed citations
20.
Davidson, M. & S Mukherjee. (1982). Progression of olfactory reference syndrome to mania: a case report. American Journal of Psychiatry. 139(12). 1623–1624. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Josiane Bourque Breakdown of academic impact, for papers by Major R. Bradshaw Breakdown of academic impact, for papers by Leticia González-Blanco Breakdown of academic impact, for papers by Alison Merikangas Breakdown of academic impact, for papers by Rachel Galioto Breakdown of academic impact, for papers by Antonietta Scaffidi Breakdown of academic impact, for papers by Liis Merenäkk Breakdown of academic impact, for papers by Laura M. Huckins Breakdown of academic impact, for papers by Laura Ortega Breakdown of academic impact, for papers by Allan M. Andersen
Rankless by CCL
2026